ALT-804

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameALT-804

Drug Alias NameTCR/IL-15+TCR/IL-15R alpha fusion protein complex (Altor)ALT-804

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy

Mechanisms of ActionInterleukin-15 modulators

TargetsInterleukin-15

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAltor Bioscience Corp

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAltor Bioscience Corp

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A